Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
MS medication withdrawn because of safety concerns
Daclizumab had known risks, but reports of adverse events led the European Medicines Agency to investigate.
News
FDA alerts doctors to stop administering compounded products
Patients could be at risk for serious harms if they receive drugs manufactured by this company.
News
Arm-placement indication for CGM approved by FDA
New indication gives patients much-desired flexibility in CGM placement.
News
Insomnia, major depressive episode linked in U.S. soldiers
“Addressing insomnia may increase resiliency and the ability to perform and cope with the complexities of active duty.”
News
Poor sleep, suicide risk linked in college students
Most students classified with suicide risk also had poor sleep quality, but the opposite was not true.
News
Delayed treatment for psychosis can have ‘deleterious’ effects
Duration of untreated psychosis appears to be correlated with decreases in hippocampal volume integrity.
News
Blood test approved for patients with concussions
The new test can quickly determine who needs CT scans – and will hopefully reduce costs.
News
Exploding e-cigs can cause grievous injuries
More teens should know about these dangers because they may be risking serious injury.
News
Pulmonary Fibrosis Foundation offers trial-finding app
A new tool that gives patients “a voice in their care process.”
News
Drug combo indicated for bacterial pneumonia
Ceftazidime/avibactam is the first new option in years for treatment of HABP/VABP caused by Gram-negative bacteria.
News
Trial seeks improved regimens for pregnant women with HIV
A new study seeks better-tolerated alternatives to the current antiretroviral regimen for pregnant women with HIV.